Showing results (921-930 of 1,080) with videos related to
Sort By:
Pageof 108
Bone Marrow Transplantation|November 3, 2009
Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility studyS R Yoon, Y S Lee, S H Yang, et al.Investigational New Drugs|May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancerR S Finn, D H Ahn, M M Javle, et al.Oncogene|August 29, 2017
Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesisJ-L Park, Y-S Lee, M-J Song, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Changes in Prescribing Patterns in Stage III Colon CancerFang-Shu Ou, Daniel J Walden, Joseph J Larson, et al.Journal of Viral Hepatitis|January 10, 2018
Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antiviralsH Cho, H Ahn, D H Lee, et al.Photochemistry and Photobiology|June 4, 2015
Measuring the Physiologic Properties of Oral Lesions Receiving Fractionated Photodynamic TherapyShannon M Gallagher-Colombo, Harry Quon, Kelly M Malloy, et al.The Oncologist|October 14, 2022
The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-AnalysisMohamad Bassam Sonbol, Rabbia Siddiqi, Pedro Luiz Serrano Uson, et al.Nature|April 17, 2020
A neural circuit mechanism for mechanosensory feedback control of ingestionDong-Yoon Kim, Gyuryang Heo, Minyoo Kim, et al.ESMO Open|August 26, 2021
Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11)E H Cho, J-Y Kim, S-A Im, et al.Pharmacogenetics|July 4, 2001
Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancerD S Yim, S K Parkb, K Y Yoo, et al.Pageof 108